PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Escudier, Bernard
TI  - A Randomized, Controlled, Double-Blind Phase 3 Study of Bevacizumab/Interferon-α2a vs Placebo/Interferon- α2a as First-line Therapy in Metastatic Renal Cell Carcinoma
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 12--13
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/12.2.short
4100  - http://mdc.sagepub.com/content/7/3/12.2.full
AB  - The AVOREN trial was conducted to compare interferon alone with interferon plus bevacizumab for the treatment of metastatic renal cell carcinoma (RCC). The findings of the trial represent an important step in the recent advances in the treatment of RCC.